Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q9H3M9
UPID:
ATX3L_HUMAN
Alternative names:
Machado-Joseph disease protein 1-like
Alternative UPACC:
Q9H3M9; B2RNY8
Background:
Ataxin-3-like protein, also known as Machado-Joseph disease protein 1-like, is a deubiquitinating enzyme. It plays a crucial role in cellular processes by cleaving both 'Lys-48'-linked and 'Lys-63'-linked poly-ubiquitin chains in vitro, showcasing its versatility in protein degradation pathways.
Therapeutic significance:
Understanding the role of Ataxin-3-like protein could open doors to potential therapeutic strategies. Its unique ability to process different types of poly-ubiquitin chains suggests its involvement in a wide range of cellular functions and diseases.